A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
about
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics StudiesInnovation in metabolomics to improve personalized healthcareDiscrimination of human semen specimens by NMR data, sperm parameters, and statistical analysis.Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cellsQuantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levelsPattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.NMR-based metabolomics approach to target biomarkers for human prostate cancer.Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem.Markers for detection of prostate cancer.Metabolomics: a novel approach to early and noninvasive prostate cancer detection.A decade in prostate cancer: from NMR to metabolomics.Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers.High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics.NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.Physical analysis of ejaculate to evaluate the secretory activity of the seminal vesicles and prostate.Profiling Prostate Cancer Therapeutic Resistance.
P2860
Q26738585-3A4E1B8A-9053-450C-BFD6-3B414092B25AQ26830021-E284580F-DCF1-468A-9928-C3AE900BB05EQ30984694-CCEEAFC2-8E81-4231-9AFA-CDE2C0C0EB2AQ36162068-C60F46D5-1622-4CE2-9801-A8033D60143EQ36498760-8FCAFCF6-AC42-44D9-9CE2-34C27795E1EBQ36607286-F33FC295-E246-4908-9A97-7D203A7A6714Q36841884-A928A738-18F5-4EC2-9096-F238294079ECQ37203925-A826215F-8BC8-474F-A6AD-A4C1489F75D7Q37328403-C184BF67-9A6C-4895-96A2-91E5778648ACQ37850315-D1CEA2AE-A460-4E01-B657-A6680800CF9BQ37876681-C7A46F72-0543-4C3E-B34E-AA946BB587A9Q37981214-43C1F210-9EB6-47BF-B3D1-D0B1521CBC94Q38119455-8391E8B9-F073-44D6-82A3-0A05F32B2056Q38336321-2015A12C-861B-47BE-ACDB-0395BB33E654Q38767020-CE5149D2-7A5F-418F-8A45-521774FD0F23Q39752333-560D736B-60B7-497E-BCAF-E94B0719FF6DQ46758835-BD409708-7C83-4614-8B88-B9F8BBCD4008Q52644478-916D8CC5-77A4-4F2E-BE17-865D5541325E
P2860
A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
A decrease in 1H nuclear magne ...... nt of prostate adenocarcinoma.
@ast
A decrease in 1H nuclear magne ...... nt of prostate adenocarcinoma.
@en
type
label
A decrease in 1H nuclear magne ...... nt of prostate adenocarcinoma.
@ast
A decrease in 1H nuclear magne ...... nt of prostate adenocarcinoma.
@en
prefLabel
A decrease in 1H nuclear magne ...... nt of prostate adenocarcinoma.
@ast
A decrease in 1H nuclear magne ...... nt of prostate adenocarcinoma.
@en
P2093
P1476
A decrease in 1H nuclear magne ...... ent of prostate adenocarcinoma
@en
P2093
Anthony Y Smith
Eric E Kline
Tiffany A Averna
P304
P356
10.1097/01.JU.0000148949.72314.D7
P407
P577
2005-02-01T00:00:00Z